EUVIMEDEUVIMED entdecken
Crossref

Digital SERS Nanoprobe Immunoassay With Single‐Particle Sensing Resolution for Detection of Pancreatic Cancer Biomarkers From Clinical Blood Samples

Chanhee Choi, Hongwon Kim, Sohyun Moon, In-Jun Hwang, Seong-Yeon Choi, Seokhyun Yoon, Jin-Hyeok Hwang, Kwangrok Jung, Jong-Chan Lee, Jong-Ho Kim iD

Small Methods · 2026-05 · 10 (9)

DOI: 10.1002/smtd.202600005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small Methods, online erschienen am 08.04.2026. Verfasst von Chanhee Choi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Materials Science and Chemical Engineering, Hanyang University, Ansan, Republic of Korea. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Biomarkers, Tumor, Spectrum Analysis, Raman. Die Arbeit nennt 50 Literaturangaben. Gefördert von: National Research Foundation of Korea (NRF), Korea Planning & Evaluation Institute of Industrial Technology (KEIT), National Research Council of Science & Technology (NST).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Surface‐enhanced Raman scattering (SERS) nanoprobe‐based immunoassay is an emerging liquid biopsy modality for the detection of blood biomarkers. However, quantitative detection of blood biomarkers using SERS nanoprobe immunoassays remains challenging, primarily due to intrinsic stochastic fluctuations of SERS signals. Herein, Ag nanogap shells (AgNGS) encoded with Raman labels are prepared as SERS nanoprobes with single‐particle sensing resolution and long‐term structural and signal stability. Then, digital SERS nanoprobe immunoassays using AgNGS nanoprobes and magnetic nanoparticles conjugated with detection and capture antibodies for carbohydrate antigen 19‐9 (CA19‐9) and apolipoprotein A1 (APOA1) are developed for their quantitative detection in the clinical serum samples of pancreatic cancer (PC). Furthermore, digitization of the SERS intensity‐based assay outcomes into On/Off states allows significant improvement in limits of detection and quantification for biomarker detection. Finally, the digital AgNGS nanoprobe immunoassay enables quantitative detection of both CA19‐9 and APOA1 from the 150 clinical serum samples of PC patients, which are integrated with machine learning analysis via bootstrap sampling and logistic regression modeling for the diagnosis of early‐stage PC, achieving a high AUC of 0.988. AgNGS nanoprobe immunoassays offer an effective liquid biopsy route for profiling various blood biomarkers associated with many diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsBiomarkers, TumorSpectrum Analysis, RamanHumansImmunoassaySilverMetal NanoparticlesCA-19-9 AntigenApolipoprotein A-I

Stichwörter der Autor:innen

blood biomarker detectiondigital SERS nanoprobe immunoassayliquid biopsypancreatic cancersurface‐enhanced Raman scattering

Substanzen

Biomarkers, TumorSilverCA-19-9 AntigenApolipoprotein A-I

Autor:innen und Institutionen

  • Department of Materials Science and Chemical Engineering, Hanyang University, Ansan, Republic of Korea.
  • School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, Georgia, USA.
  • Department of Electronics & Electrical Engineering, College of Engineering, Dankook University, Yongin, Republic of Korea.
  • Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea.

ORCID-Profile: Jong-Ho Kim

Förderung

  • National Research Foundation of Korea (NRF)
  • Korea Planning & Evaluation Institute of Industrial Technology (KEIT)
  • National Research Council of Science & Technology (NST)

Zitieren

APA

Choi, C., Kim, H., Moon, S., Hwang, I. J., Choi, S. Y., Yoon, S., Hwang, J. H., Jung, K., Lee, J. C., & Kim, J. H. (2026). Digital SERS Nanoprobe Immunoassay With Single‐Particle Sensing Resolution for Detection of Pancreatic Cancer Biomarkers From Clinical Blood Samples. Small Methods, 10(9). https://doi.org/10.1002/smtd.202600005

Vancouver

Choi C, Kim H, Moon S, Hwang IJ, Choi SY, Yoon S, et al. Digital SERS Nanoprobe Immunoassay With Single‐Particle Sensing Resolution for Detection of Pancreatic Cancer Biomarkers From Clinical Blood Samples. Small Methods. 2026;10(9). doi:10.1002/smtd.202600005

BibTeX
@article{Choi2026,
  author = {Choi, Chanhee and Kim, Hongwon and Moon, Sohyun and Hwang, In-Jun and Choi, Seong-Yeon and Yoon, Seokhyun and Hwang, Jin-Hyeok and Jung, Kwangrok and Lee, Jong-Chan and Kim, Jong-Ho},
  title = {Digital SERS Nanoprobe Immunoassay With Single‐Particle Sensing Resolution for Detection of Pancreatic Cancer Biomarkers From Clinical Blood Samples},
  journal = {Small Methods},
  year = {2026},
  volume = {10},
  number = {9},
  doi = {10.1002/smtd.202600005}
}
Kostenlos starten →